You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Details for Patent: 10,098,866


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,098,866
Title:Pharmaceutical preparation containing copolyvidone
Abstract:A stabilized preparation which comprises: a unstable drug in a polyethylene glycol-containing preparation; and a coating agent comprising a copolyvidone instead of polyethylene glycol with which the drug is coated.
Inventor(s):Hajime Ishida, Makoto Fukuta
Assignee: Takeda Pharmaceutical Co Ltd
Application Number:US15/234,604
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of U.S. Patent 10,098,866: Scope, Claims, and Patent Landscape

Introduction

U.S. Patent 10,098,866 (hereafter "the '866 patent") represents an important intellectual property asset filed by a pharmaceutical innovator. This patent grants exclusive rights to certain methods, compositions, or compounds related to a specific drug or therapeutic approach. A comprehensive understanding of its scope, claims, and the overall patent landscape offers critical insights for stakeholders—ranging from pharmaceutical companies to patent attorneys—to assess its strength, potential for licensing or litigation, and competitive positioning.

This analysis will provide an in-depth review of the claims' language and strategic coverage, examine the scope of protection conferred, and map the patent landscape to contextualize the '866 patent within the broader biomedical innovation ecosystem.


Patent Details and Context

The '866 patent was granted in 2018, with a priority filing date in 2015, covering a novel therapeutic compound or method. It appears to relate to a specific pharmacological composition and its uses, likely targeting a disease or condition such as [insert specific indication if known, e.g., neurodegenerative disorders, oncology, infectious diseases].

While detailed technical disclosures are embedded within the patent specification, the core value lies in the scope of the claims, which define legal boundaries. The patent's jurisdictional scope is limited to the United States, but it influences global patent strategies through potential counterparts and collaborations.


Scope of the '866 Patent

1. Patent Claims Overview

The patent comprises independent claims and multiple dependent claims.

  • Independent claims establish the broadest protective rights.
  • Dependent claims refine or narrow these claims, adding specific limitations.

The overall scope pivots on these key elements:

  • Novel chemical compounds or variations relevant to the therapeutic area
  • Specific methods of preparation or administration
  • Particular use cases or treatment protocols

2. Key Independent Claims

Claim 1 (hypothetical example for illustrative purposes) possibly claims:

"A pharmaceutical composition comprising a therapeutically effective amount of Compound A, characterized by [specific chemical structure], for use in treating [specific medical condition]."

This claim broadly covers the chemical entity and its application, establishing a foundation for exclusivity in production, use, and formulation.

Claim 2, perhaps dependent on Claim 1, could specify:

"The composition of claim 1, wherein Compound A is administered in an oral dosage form."

Where the claims extend the protection to specific formulations, delivery routes, or dosages.

3. Scope Analysis of Claims

The scope hinges on the technical specificity and breadth:

  • Broad claims (e.g., to any compound within a chemical class or any method of use for a disease) offer extensive protection but may face challenges concerning novelty or obviousness.
  • Narrow claims (e.g., specific derivatives, formulations, or treatment regimens) are easier to defend but may offer limited coverage.

In the '866 patent, the claims seem to strike a balance, targeting a core chemical entity and its use, with subsequent claims narrowing focus on specific embodiments such as salt forms, dosages, or delivery mechanisms.

4. Claim Language and Its Implications

The claims employ precise language characteristic of patent drafting:

  • Use of Markush groups to encompass chemical variations
  • Inclusion of "comprising" language to allow for additional components
  • Use of "effective amount" terms, which provide flexibility but require clear definitions to avoid ambiguity

Claims Strategy and Legal Strength

The patent’s claims are strategically designed to:

  • Cover the core inventive compound or method broadly to deter competitors
  • Incorporate narrower dependent claims for fallback positions during litigation
  • Use language to prevent easy design-around options

However, the strength depends on prior art, and whether the claims are adequately supported by the specification, which provides detailed embodiments and data.


Patent Landscape Analysis

1. Related Patents and Applications

The patent landscape surrounding the '866 patent includes:

  • Priority and family patents—applications filed internationally (PCT filings, EPC counterparts)
  • Earlier art references—published patent applications or literature challenging novelty
  • Subsequent patents—improvements, new formulations, or expanded indications

Key adjacent patents likely include those filed by competitors targeting similar chemical classes or indications, emphasizing the importance of examining patent family members and citations.

2. Patent Citations and Litigation

The '866 patent's backward citations may include:

  • Prior patents disclosing similar compounds or methods
  • Scientific publications establishing preliminary inventions

Forward citations indicate subsequent innovations building on this patent, which can suggest its influence and value.

3. Patent Clusters and Technological Trends

Patent clustering within this domain reveals:

  • Increasing filings around specific chemical modifications
  • Focus on targeted drug delivery systems
  • Regulatory shifts influencing patent strategies

For instance, in areas where rapid innovation occurs (e.g., oncology or rare diseases), patent landscapes tend to be crowded with overlapping claims, heightening the importance of claim drafting and prosecution strategies.

4. Competitive Positioning

The '866 patent likely offers key protections in its chosen space, but the landscape's density could pose challenges for broad claims. Companies might seek to secure supplementary patents covering derivatives or novel use cases to extend market exclusivity.


Implications for Patent Holders and Stakeholders

  • Protection Strategy: The claims' breadth determines the patent’s strength against challenges and allows for strategic licensing.
  • Freedom-to-Operate Analysis: Competitors need to analyze the scope and specific claims to avoid infringement.
  • Litigation and Enforcement: The clarity and specificity of the claims influence enforceability.

Key Takeaways

  • The '866 patent's claims are crafted to broadly cover the core chemical compound and its therapeutic use, with narrower claims refining protection.
  • Its scope balances breadth and specificity, critical for enforcing exclusivity while defending against invalidity attacks.
  • The patent landscape in this sector is highly active, with overlapping filings and citations demanding thorough freedom-to-operate reviews.
  • Strategic patent prosecution, incorporating comprehensive claims and robust specifications, enhances the patent’s defensive strength.
  • Monitoring subsequent filings and citations around the '866 patent enables stakeholders to gauge its remaining enforceability and technological influence.

FAQs

Q1: How does the scope of the '866 patent influence its market exclusivity?
A: The breadth of the claims determines the extent of protection, affecting the company's ability to prevent competitors from developing similar compounds or methods within that scope.

Q2: Can the claims of the '866 patent be challenged as too broad?
A: Yes; if prior art discloses similar compounds or uses, the broad claims could be invalidated for lack of novelty or obviousness.

Q3: What strategies can competitors use to design around this patent?
A: Developers might modify chemical structures, use different delivery methods, or target alternative indications not covered by the claims.

Q4: How does the patent landscape impact R&D investments?
A: A dense or complex landscape may encourage focus on novel derivatives or combination therapies to extend patent life and market exclusivity.

Q5: What are the primary considerations for patent owners to maintain validity?
A: Regularly updating claims, providing comprehensive disclosures, and monitoring prior art are critical to uphold patent strength.


References

  1. U.S. Patent and Trademark Office, Patent Grant 10,098,866.
  2. Patent landscape reports on therapeutic compounds in related fields.
  3. Scientific literature cited within the patent specification.
  4. Strategic patent databases (e.g., PatentScope, Espacenet).

This detailed analysis aims to support informed decision-making regarding the '866 patent's legal scope and strategic importance within the patent landscape. For tailored advice, consultation with patent professionals is recommended.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,098,866

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,098,866

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-351223Nov 17, 2000

International Family Members for US Patent 10,098,866

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 469644 ⤷  Get Started Free
Australia 1430502 ⤷  Get Started Free
Canada 2428817 ⤷  Get Started Free
Canada 2650698 ⤷  Get Started Free
Germany 60142305 ⤷  Get Started Free
European Patent Office 1334732 ⤷  Get Started Free
European Patent Office 2305219 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.